David Ian Highton

age:

56 years

appointments:

15 active

7 prior

primary industry:

Scientific research and development

about David

Since 2017, Mr Highton has been a director of 22 companies, the current directorship have a combined turnover of approximately £3.6b.

Combined Valuation

£9.4b

Combined Turnover

£3.6b

active directorships over time

company
turnover
valuation
start
end
status
role
pfizer limited£3.1b£5.3bJun 2022-OpenDirector
pfizer development services (uk) limited£150.6m£1.1bFeb 2021-OpenDirector
reviral limited£6.1m£693.6mJun 2022-OpenDirector
reviral limited£6.1m£693.6mJun 2022-OpenDirector
pharmacia limited£33m£643.4mFeb 2021-OpenDirector
pfizer r&d uk limited£262.4m£609.7mJun 2022-OpenDirector
john wyeth & brother limited£0£213.1mFeb 2021-OpenDirector
global blood therapeutics uk limited£1.7m£35.4mApr 2023-OpenDirector
g.d.searle & co.limited-£33mJul 2017-OpenDirector
seagen u.k. ltd.£7.5m£15.5mDec 2023-OpenDirector
pfizer consumer healthcare£0£8.1mFeb 2021-OpenDirector
hospira aseptic services limited£0£641.6kAug 2020-OpenDirector
pfizer specialty uk limited£0£0Jul 2017-OpenDirector
neusentis limited£0£0Feb 2021-OpenDirector